Permutation Tests for Phase III Clinical Trials

  • Vance Berger
  • Anastasia Ivanova


The opinions and assertions expressed in this chapter are the private views of the authors. No endorsement by the Food and Drug Administration or the University of North Carolina at Chapel Hill is intended or should be inferred.


Permutation Test Sample Space Adaptive Test Rejection Region Extreme Region 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Berger, V.W. (1998). Admissibility of exact conditional tests of stochastic order. Journal of Statistical Planning and Inference 66 (1), 39 - 50.MathSciNetzbMATHCrossRefGoogle Scholar
  2. Berger, V.W. (2000). Pros and cons of permutation tests. Statistics in Medicine 19, 1319 - 1328.CrossRefGoogle Scholar
  3. Berger, V.W. and Exner, D.V. (1999). Detecting selection bias in randomized clinical trials. Controlled Clinical Trials 20, 319 - 327.CrossRefGoogle Scholar
  4. Berger, V.W., Permutt, T., and Ivanova, A. (1998). The convex hull test for ordered categorical data. Biometrics 54 (4), 1541 - 1550.zbMATHCrossRefGoogle Scholar
  5. Berger, V.W. and Sackrowitz, H. (1997). Improving tests for superior treatment in contingency tables. Journal of the American Statistical Association 92, 700 - 705.MathSciNetzbMATHCrossRefGoogle Scholar
  6. Berry, G. and Armitage, P. (1995). Mid-P confidence intervals: A brief overview. The Statistician 44 (4), 417 - 423.CrossRefGoogle Scholar
  7. Chalmers, T.C., Celano, P., Sacks, H.S., and Smith, H. (1983). Bias in treatment assignment in controlled clinical trials. The New England Journal of Medicine 309, 1358 - 1361.CrossRefGoogle Scholar
  8. Ederer, F. (1975). Why do we need controls? Why do we need to randomize? American Journal of Ophthalmology 76, 758 - 762.Google Scholar
  9. Edgington, E.S. (1995). Randomization Tests, 3rd ed. Marcel Dekker, New York.zbMATHGoogle Scholar
  10. Fox, S.M., Einhorn, L.H., Cox, E, Powell, N., and Abdy, A. (1993). Ondansetron versus ondansetron, dexamethasone, and chlorpromazine in the prevention of nausea and vomiting associated with multiple-day cisplatin chemotherapy. Journal of Clinical Oncology 11, 2391 - 2395.Google Scholar
  11. Kimeldorf, G., Sampson, A.R., and Whitaker, L.R. (1992). Min and max scorings for two-sample ordinal data. Journal of the American Statistical Association 87, 241 - 247.MathSciNetCrossRefGoogle Scholar
  12. Kuritz, S.J., Landis, J.R., and Koch, G.G. (1988). A general overview of Mantel-Haenszel methods. Annual Review of Public Health 9, 123 - 160.CrossRefGoogle Scholar
  13. Ludbrook, J. and Dudley, H. (1998). Why permutation tests are superior to t and F tests in biomedical research. The American Statistician 52(2), 127132.Google Scholar
  14. McKinlay, J. B. and Marceau, L. D. (1999). A tale of three tails. The American Journal of Public Health 89 (3), 295 - 298.CrossRefGoogle Scholar
  15. Miller, R.G. (1980). Combining 2x2 contingency tables. In: Miller R.G., Efron B., Brown B.W., and Moses L.E., eds. Biostatistics Casebook. Wiley, New York.Google Scholar
  16. Permutt, T. and Hebel, J.R. (1989). Simultaneous-equation estimation in a clinical trial of the effect of smoking on birth weight. Biometrics 45, 619622.Google Scholar
  17. Placebo Working Group (1996). Placebo effects and research in alternative and conventional medicine. Chinese Journal of Integrated Medicine 2(2), 141148.Google Scholar
  18. Sacks, H., Chalmers, T.C., and Smith, H. (1982). Randomized versus historical controls for clinical trials. The American Journal of Medicine 72, 233 - 240.CrossRefGoogle Scholar
  19. Simon, R. (1982). Randomized clinical trials and research strategy. Cancer Treatment Reports 66 (5), 1083 - 1087.Google Scholar
  20. Upton, G.J.G. (1982). A comparison of alternative tests for the 2x2 comparative trial. Journal of the Royal Statistical Society A 145 (1), 86 - 105.MathSciNetGoogle Scholar
  21. Upton, G.J.G. (1992). Fisher’s exact test. Journal of the Royal Statistical Society A 155 (3), 395 - 402.CrossRefGoogle Scholar
  22. Vickers, A., Cassileth, B., Ernst, E., Fisher, P., Goldman, P., Jonas, W., Lewith, G., Schulz, K., and Silagy, C. (1997). How should we research unconventional therapies? International Journal of Technology Assessment in Health Care 13 (1), 111 - 121.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2001

Authors and Affiliations

  • Vance Berger
    • 1
  • Anastasia Ivanova
    • 2
  1. 1.U.S. Food and Drug AdministrationUSA
  2. 2.University of North CarolinaChapel HillUSA

Personalised recommendations